This Article Abstract Full Text (PDF) Data Supplement All Versions of this Article: 102/10/1247    most recent CIRCRESAHA.108.172379v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dora, K. A. Articles by Garland, C. J. Search for Related Content PubMed PubMed Citation Articles by Dora, K. A. Articles by Garland, C. J. Related Collections Ion channels/membrane transport Endothelium/vascular type/nitric oxide Other Vascular biology Related Article

(Circulation Research. 2008;102:1247.)
© 2008 American Heart Association, Inc.

Cellular Biology

Modulation of Endothelial Cell K_Ca3.1 Channels During Endothelium-Derived Hyperpolarizing Factor Signaling in Mesenteric Resistance Arteries

Kim A. Dora, Nicola T. Gallagher, Alister McNeish, Christopher J. Garland

From the Department of Pharmacy and Pharmacology, University of Bath, Claverton Down, United Kingdom.

Correspondence to Christopher J. Garland, Department of Pharmacy and Pharmacology, University of Bath, Claverton Down, Bath, BA2 7AY, United Kingdom. E-mail c.j.garland{at}bath.ac.uk

	Abstract

Top Abstract Introduction Materials and Methods Results Discussion References

 
Arterial hyperpolarization to acetylcholine (ACh) reflects coactivation of K_Ca3.1 (IK_Ca) channels and K_Ca2.3 (SK_Ca) channels in the endothelium that transfers through myoendothelial gap junctions and diffusible factor(s) to affect smooth muscle relaxation (endothelium-derived hyperpolarizing factor [EDHF] response). However, ACh can differentially activate K_Ca3.1 and K_Ca2.3 channels, and we investigated the mechanisms responsible in rat mesenteric arteries. K_Ca3.1 channel input to EDHF hyperpolarization was enhanced by reducing external [Ca²⁺]_o but blocked either with forskolin to activate protein kinase A or by limiting smooth muscle [Ca²⁺]_i increases stimulated by phenylephrine depolarization. Imaging [Ca²⁺]_i within the endothelial cell projections forming myoendothelial gap junctions revealed increases in cytoplasmic [Ca²⁺]_i during endothelial stimulation with ACh that were unaffected by simultaneous increases in muscle [Ca²⁺]_i evoked by phenylephrine. If gap junctions were uncoupled, K_Ca3.1 channels became the predominant input to EDHF hyperpolarization, and relaxation was inhibited with ouabain, implicating a crucial link through Na⁺/K⁺-ATPase. There was no evidence for an equivalent link through K_Ca2.3 channels nor between these channels and the putative EDHF pathway involving natriuretic peptide receptor-C. Reconstruction of confocal z-stack images from pressurized arteries revealed K_Ca2.3 immunostain at endothelial cell borders, including endothelial cell projections, whereas K_Ca3.1 channels and Na⁺/K⁺-ATPase ₂/₃ subunits were highly concentrated in endothelial cell projections and adjacent to myoendothelial gap junctions. Thus, extracellular [Ca²⁺]_o appears to modify K_Ca3.1 channel activity through a protein kinase A–dependent mechanism independent of changes in endothelial [Ca²⁺]_i. The resulting hyperpolarization links to arterial relaxation largely through Na⁺/K⁺-ATPase, possibly reflecting K⁺ acting as an EDHF. In contrast, K_Ca2.3 hyperpolarization appears mainly to affect relaxation through myoendothelial gap junctions. Overall, these data suggest that K⁺ and myoendothelial coupling evoke EDHF-mediated relaxation through distinct, definable pathways.

Key Words: potassium channel • endothelial cells • hyperpolarization • membrane potential • electrophysiology • vasodilation

	Introduction

Top Abstract Introduction Materials and Methods Results Discussion References

 
The importance of the arterial endothelium for relaxation of the subjacent smooth muscle is well established. Whatever the final endothelium-derived effector, a key event is an initial increase in endothelial cell [Ca²⁺]_i. In the case of endothelium-derived hyperpolarizing factor (EDHF) (the NO- and prostanoid-independent pathway), this increase crucially activates endothelial K_Ca2.3 and K_Ca3.1 channels. Activation of these K_Ca channels leads on to arterial hyperpolarization and dilation (see elsewhere for review¹), and a changing role for each subtype has been implicated in pathological responses within blood vessels.^2,3

Although activation of both K_Ca2.3 and K_Ca3.1 channels leads ultimately to vascular dilation, each can provide a variable contribution to EDHF hyperpolarization. Individual input is influenced by the extent of ongoing arterial (background) constriction. Increasing endothelial cell [Ca²⁺]_i (with acetylcholine [ACh]) in quiescent rat mesenteric arteries hyperpolarizes the resting membrane potential through K_Ca2.3 channels alone, but, during smooth muscle depolarization and the associated contraction necessary to observe EDHF relaxation, K_Ca3.1 channels are also activated.⁴ This differential activation correlates with a distinct subcellular distribution of the channels. K_Ca3.1 channels are localized within the endothelial cell projections through the internal elastic lamina (IEL) that form myoendothelial gap junction (MEGJs) with the adjacent smooth muscle. In contrast, K_Ca2.3 channels are diffusely distributed throughout the plasmalemma of endothelial cells.⁵ How the different channel types are activated independently is not known, but concentrating K_Ca3.1 channels within the narrow endothelial cell projections may hinder access of activating Ca²⁺ from the main body of the endothelial cells, while, perhaps, facilitating activation by a signal derived from or associated with the contracting smooth muscle. In small arteries and arterioles, Ca²⁺ and/or a Ca²⁺ signal has been shown to spread from the muscle to the endothelium.^6–8 In the mesenteric artery, this process relies on Ca²⁺ signaling via MEGJs.^7,8 Extracellular Ca²⁺ levels ([Ca²⁺]_o) may also have a significant influence on endothelial cell signaling. In the mesenteric artery, an extracellular calcium-sensing receptor (CaSR) on the endothelium links to activate K_Ca3.1 channels selectively and appears to colocalize with this channel (but not with K_Ca2.3 channels).⁹ This raises the possibility that alterations in extracellular Ca²⁺ concentration may help determine the relative contribution from K_Ca3.1/2.3 channels. In addition, K_Ca3.1 but not K_Ca2.3 channel activity is inhibited by protein kinase A phosphorylation in enteric neurons, indicating regulation may occur independently of intracellular [Ca²⁺] change.^10–12

In the rat mesenteric artery, transfer of endothelial hyperpolarization to the muscle, in part, reflects K⁺ ion efflux through endothelial K_Ca channels and, in part, spread of hyperpolarization via MEGJs.^13–16 Extracellular K⁺, mimicking its action as a diffusible EDHF, stimulates smooth muscle hyperpolarization and relaxation primarily by activating Na⁺/K⁺-ATPase.¹⁷ However, in situ, the ability of K⁺ to act as an EDHF is inversely related to ongoing arterial contraction because, as contraction increases, Na⁺/K⁺-ATPase activity is swamped by K⁺ leaving the smooth muscle through BK_Ca channels.^17–19 In contrast, MEGJs operating in parallel to K⁺ enable a constant spread of hyperpolarization, and this route to relaxation thus becomes predominant as arterial tone approaches maximum.¹⁶ Therefore, 1 possibility is that K_Ca2.3 and K_Ca3.1 channels may each separately underlie 1 of these routes to vasodilation. In support of this possibility, recent evidence from rat mesenteric artery has suggested that K_Ca2.3 channel activation may be intimately linked to the release of C-type natriuretic peptide, which acts as a diffusible EDHF through natriuretic peptide receptor-C.²⁰

The aims of the present study were, therefore: (1) to investigate how K_Ca3.1 channels are independently activated; and (2) to show whether the subcellular distribution of K_Ca2.3/K_Ca3.1 channels within rat mesenteric endothelial cells can be correlated with discrete EDHF pathways, with functional consequences for relaxation and of direct relevance to endothelial changes associated with vascular disease.

	Materials and Methods

Top Abstract Introduction Materials and Methods Results Discussion References

 
An expanded Materials and Methods section in the online data supplement, available at http://circres.ahajournals.org, gives full details regarding the experimental techniques used. These included intracellular sharp microelectrode recording and simultaneous tension measurements, Ca²⁺ imaging from both smooth muscle and endothelial cells, and immunohistochemistry of rat isolated small mesenteric arteries.

	Results

Top Abstract Introduction Materials and Methods Results Discussion References

 
Reducing External [Ca²⁺]_o Recruits K_Ca3.1 Channel Input to EDHF Hyperpolarization
Reducing external [Ca²⁺]_o from 2.5 to 1.0 mmol/L slightly reduced smooth muscle resting membrane potential (from –51.7±1.6 to –47.8±0.9 mV, n=7 and 12) and depressed the cumulative EDHF hyperpolarization to ACh (maximal increase 23.9±2.4 mV [n=7] and 20.1±1.7 mV [n=12], respectively; Figure 1A). In contrast to the situation in 2.5 mmol/L Ca²⁺ (and see also Crane et al⁴), apamin failed to block EDHF hyperpolarization in 1 mmol/L Ca²⁺ (n=4). Furthermore, low [Ca²⁺]_o facilitated the ability of the K_Ca3.1 channel activator 1-EBIO (100 and 300 µmol/L) to evoke smooth muscle hyperpolarization (Figure 1B). In separate experiments using 1.0 mmol/L [Ca²⁺]_o with apamin present (resting membrane potential: –48.6±1.8 mV, n=8), 1 µmol/L forskolin significantly reduced EDHF hyperpolarization by 80% to 100% (Figure 1C) and hyperpolarization to 300 µmol/L 1-EBIO from 8.5±1.9 mV to 2.9±0.9 mV (n=5).

View larger version (16K): [in this window] [in a new window]   Figure 1. Summarized data showing the average change in membrane potential (Em) to cumulative increases in [ACh] applied to evoke EDHF hyperpolarization in mesenteric arteries. A, Reducing [Ca2+]o from 2.5 to 1.0 mmol/L depressed the steady-state hyperpolarization to ACh (n=7 and 12, respectively). In 1.0 mmol/L Ca2+ and with 50 nmol/L apamin present, 50% hyperpolarization remained (n=4), whereas in 2.5 mmol/L [Ca2+]o, apamin fully blocked hyperpolarization (n=13). B, Histogram summarizing the increase in smooth muscle membrane potential following endothelial cell stimulation with 1-EBIO in the presence of 50 nmol/L apamin. In 1.0 mmol/L [Ca2+]o, hyperpolarization to both 100 and 300 µmol/L 1-EBIO was enhanced (n=4 and 5, respectively). *P<0.05 relative to control (2.5 mmol/L [Ca2+]o). C, In 1.0 mmol/L [Ca2+]o Krebs with 50 nmol/L apamin present, EDHF hyperpolarization evoked with ACh was significantly inhibited in the additional presence of 1 µmol/L forskolin (n=8, P<0.05).

Alteration in [Ca²⁺]_o also modified arterial tone (Figure I in the online data supplement). Increasing [Ca²⁺]_o from 1.0 mmol/L relaxed precontracted arteries via endothelial cell K_Ca3.1 channels, with complete relaxation obtained in the presence of 2.5 mmol/L [Ca²⁺]_o.

Limiting Smooth Muscle Ca²⁺ Increase Modifies K_Ca2.3 and K_Ca3.1 Channel Input to EDHF Dilation in Rat Mesenteric Arteries
In the presence of the voltage-gated Ca²⁺ channel (VGCC) inhibitor nifedipine (10 µmol/L) and during depolarization to phenylephrine (PE) (1 µmol/L: 7.2±1.8 mV, n=12), apamin (50 nmol/L) alone effectively abolished EDHF hyperpolarization (23.4±1.3 mV hyperpolarization to 3 µmol/L ACh reduced to 1.9±1.3 mV, n=12) (Figure 2A through 2C), whereas TRAM-34 (1 µmol/L) had little effect (hyperpolarization to 3 µmol/L ACh 19.6±1.4 mV, n=12) (Figure 2B). Hyperpolarization to the direct K_Ca3.1 channel activator 1-EBIO (100 or 300 µmol/L) was not altered by nifedipine (control: 3.9±1.0 and 8.8±0.8 mV, n=4; versus nifedipine: 3.5±0.7 and 6.2±2.2 mV, n=5, respectively). In the presence of another VGCC inhibitor, diltiazem (10 µmol/L), and PE depolarization (7.0±0.9 mV, n=6), apamin again effectively abolished EDHF hyperpolarization (33.0±1.5 mV hyperpolarization to 3 µmol/L ACh reduced to 5.6±2.2 mV, n=6) (Figure 2C), whereas subsequent addition of the ATP-sensitive K⁺ (K_ATP) channel opener levcromakalim (3 µmol/L) evoked a robust hyperpolarization of 29.4±3.9 mV (n=6). Nifedipine reduced the smooth muscle cell [Ca²⁺]_i and tension increase to PE (Figure 2D through 2F).

View larger version (32K): [in this window] [in a new window]   Figure 2. ACh-mediated stimulation of KCa3.1 channels is prevented by blocking VGCC in rat mesenteric arteries. A, Original traces demonstrating concentration-dependent EDHF-induced smooth muscle hyperpolarization evoked by ACh in the presence of nifedipine (10 µmol/L) and prior depolarization to PE. Hyperpolarization overshot the resting membrane potential (dashed line) and was abolished by apamin (50 nmol/L). B, Summarized data showing the average change in membrane potential (Em) to cumulative increases in [ACh] in arteries stimulated with PE in the presence of nifedipine (10 µmol/L, n=4 to 10) or in the additional presence of either apamin (50 nmol/L, n=4 to 12) or TRAM-34 (1 µmol/L, n=7 to 14) or both inhibitors together (n=5 to 8). C, Summarized data showing the average change in membrane potential (Em) to cumulative increases in [ACh] in arteries stimulated with PE in the presence of diltiazem (10 µmol/L, n=4 to 6) or in the additional presence of apamin (50 nmol/L, n=5 to 7). D, Smooth muscle Ca2+ signals in the absence (upper traces) and presence of nifedipine (10 µmol/L, lower traces) color-coded to the field of interest shown in the image in E. Applying 0.6 or 1 µmol/L PE stimulated a marked increase in the global average level of [Ca2+] (black line), representing asynchronous Ca2+ increases within individual muscle cells. Both the average increase and the majority of the oscillations were abolished in the presence of nifedipine (see supplemental Video 1 for the movie corresponding to these data). F, Summarized data showing inhibition of the increase in [Ca2+]i stimulated by 1 µmol/L PE (control [Cont] n=6, nifedipine [Nif] n=3) (left) and the associated block of arterial contraction (paired data) (right). *P<0.05 relative to control baseline.

Imaging both global and subcellular increases in endothelial cell [Ca²⁺] to ACh failed to reveal any significant difference between ACh applied under resting conditions (baseline) compared with during smooth muscle stimulation with PE (Figure 3A and 3B). In Figure 3A, the measurement regions could be limited to the holes through the IEL, where a Ca⁺ increase was clearly observed within endothelial cell projections.

View larger version (32K): [in this window] [in a new window]   Figure 3. Similar increases in endothelial cell [Ca2+]i evoked with ACh alone and applied during smooth muscle stimulation with PE. A, Mesenteric arteries were mounted in a pressure myograph and changes in endothelial cell [Ca2+]i assessed at the interface between the endothelium and the IEL. Upper micrographs show loaded endothelial cells (average of 20 seconds). Note bright spots (endothelial cell projections) that correspond to holes in the IEL (lower micrographs). Bar=20 µm. Lower micrographs show the time course of fluorescence changes in individual endothelial cells in response to ACh (1 µmol/L) added under baseline conditions (left) and in the presence of PE (0. 3 to 0.6 µmol/L) (right). Regions were placed over (color) and adjacent to (gray) the endothelial cell projections and around the whole cell (black). The colors relate to subcellular regions within the micrographs (see supplemental Video 2 for the movie corresponding to these data from the region indicated by the black box). Representative of 3 experiments. B, Mesenteric arteries were mounted in a wire myograph, and changes in (whole) endothelial cell [Ca2+]i were measured before and during ACh (1 µmol/L), either from baseline or in the presence of PE (0.3 to 0.6 µmol/L, n=3, paired data). Note that endothelial cell projections were not loaded in these experiments. (See the expanded Materials and Methods section in the online data supplement for details.)

K_Ca3.1 Channel or Na⁺/K⁺-ATPase Block Abolishes EDHF Dilation When a Gap Junction Uncoupler Is Present
In unstimulated arteries, 30 to 60 minutes of exposure to the gap junction uncoupler carbenoxolone (100 µmol/L) did not alter either the smooth muscle (–50±1.7 and –50.6±0.9 mV, n=11 and 6, respectively) or the endothelial cell resting potential (–52.4±1.3 and –51.9±1.3 mV, n=11 and 6). With ACh, carbenoxolone reduced smooth muscle (EDHF) hyperpolarization from a maximum of 20.9±1.2 mV (to –69.7±1.7 mV, n=9) to 9.9±3 mV (to –60.5±2.7 mV, n=6) (Figure 4A and 4B) but did not reduce (direct) endothelial cell hyperpolarization to 1 µmol/L ACh (8.9±1.4 and 8.1±1.7 mV, n=5) (Figure 4C). However, it reversibly blocked the indirect hyperpolarization recorded from endothelial cells, where hyperpolarization was induced by stimulating K_ATP channels in the smooth muscle (5 µmol/L levcromakalim: control 19.8±2.1 mV, n=5; plus carbenoxolone, 0.4±0.4 mV, n=3; after washout, 19.7±2.0 mV, n=3) (Figure 4C).

View larger version (34K): [in this window] [in a new window]   Figure 4. Gap junctions facilitate the contribution of KCa2.3 channels to EDHF hyperpolarization in rat mesenteric artery. A, Original traces demonstrating ACh-mediated concentration-dependent increases in smooth muscle cell membrane potential from the resting membrane potential (dashed lines). Carbenoxolone (100 µmol/L) did not alter the resting membrane potential but reduced the hyperpolarization to ACh. B, Left, Summarized data showing the average change in membrane potential (Em) to cumulative increases in [ACh] to evoke EDHF hyperpolarization in arteries from resting membrane potential (n=6 to 11). Middle, In the presence of PE, carbenoxolone (100 µmol/L) depressed EDHF hyperpolarization (n=5 to 9) but not relaxation to ACh (n=8 to 14). Right, The EDHF-mediated relaxation was reduced by the addition of apamin (50 nmol/L, n=9 to 13) and almost abolished by TRAM-34 (1 µmol/L, n=5 to 12) or ouabain (100 µmol/L, n=3 to 9), each applied when carbenoxolone was present. *P<0.05 relative to control. C, Original traces demonstrating, Left, endothelial cell hyperpolarization to ACh (1 µmol/L) and levcromakalim (5 µmol/L). Middle, carbenoxolone (100 µmol/L) blocked hyperpolarization to levcromakalim not ACh. Right, average increases in endothelial cell membrane potential before, during application, and after washout of carbenoxlone, demonstrating reversible block of hyperpolarization to levcromakalim. ACh, n=4, 5, 3; levcromakalim, n=5, 3, 3, respectively.

Carbenoxolone (100 µmol/L) did not alter contraction to either submaximal or maximal concentrations of PE or the subsequent EDHF relaxation to ACh during submaximal contraction. However, in arteries maximally contracted with PE, the EDHF-mediated relaxation, which under these stimulation conditions relies solely on MEGJs,¹⁶ was abolished even though levcromakalim (1 µmol/L) was able to stimulate maximal relaxation (97.1±1.0%, n=6, Table).

View this table: [in this window] [in a new window]   Table 1. Table. Carbenoxolone Only Blocks EDHF Relaxation to ACh in Mesenteric Arteries Maximally Contracted With PE

In arteries submaximally stimulated with PE, depolarization and contraction did not differ from control (control: 9.2±1.0 mV, 6.3±0.4 mN; with carbenoxolone: 9.2±1.6 mV, 6.9±0.6 mN; n=8), but the ACh-evoked increase in membrane potential was reduced by 10 mV (Figure 4B), increasing to –63.4±4.5 mV (n=7) compared with –70.9±2.4 mV (n=8) without carbenoxolone. However, this reduction in maximum hyperpolarization was not sufficient to modify the associated relaxation. In contrast, in the additional presence of 1 µmol/L TRAM-34, relaxation to ACh was almost abolished (92.5±2.8% [n=5] reduced to 26.1±6.7% [n=5]; Figure 4B). Ouabain (100 µmol/L) had a similar inhibitory effect to TRAM-34, depressing relaxation to ACh (from 98.9±1.0%) to only 23.5±5.7% in the presence of carbenoxolone (n=3). In contrast, under similar conditions, apamin had only a slight inhibitory effect (Figure 4B).

Possible Link Between K_Ca2.3 Channels and C-Type Natriuretic Peptide?
Use of the selective natriuretic peptide receptor-C antagonist M372049 (100 nmol/L) and comparison of EDHF responses (to ACh) with the action of exogenous C-type natriuretic peptide (CNP) did not suggest any link between K_Ca2.3 channel activation and the subsequent activation of natriuretic peptide receptor-C leading to hyperpolarization and relaxation (supplemental Figure II).

Dimensional Localization of Na⁺/K⁺-ATPase and K Channels Within the Rat Mesenteric Artery
Immunofluorescence indicating Na⁺/K⁺-ATPase ₂ (and similarly for ₃) subunits was distributed throughout the cells within pressurized rat mesenteric arteries (Figure 5). A particularly intense, punctate fluorescence signal was discretely aligned with holes through the IEL and above the plane of focus of the endothelium, at the interface between the IEL and the smooth muscle (noted to be an endothelial cell projection²¹). This corresponds with regions of MEGJ formation where we have previously demonstrated colocalization of K_Ca3.1 channels, connexin (Cx)40, and Cx37.^5,16 In contrast, staining for K_ir2.1 channels was homogeneous within endothelial cells, and that for K_Ca2.3 channels was very clear at interendothelial cell borders, similar to staining for Cx37 and Cx40.^5,22 There was also strong staining for K_ir, K_Ca2.3, and K_Ca3.1 channels in endothelial cell projections, whereas staining for K_Ca3.1 channels and Na⁺/K⁺-ATPase was not evident (or at least markedly less) in other regions of the endothelial cells. No immunostaining was observed in arteries where the primary antibody was omitted during preparation or following prior incubation with blocking peptide.

View larger version (45K): [in this window] [in a new window]   Figure 5. Endothelial cell immunohistochemical expression pattern for Na+/K+-ATPase, Kir2.1, KCa3.1, and KCa2.3 channels in rat mesenteric arteries. A through D, Top, Confocal images of the wall of pressurized arteries showing a single z-axis plane through the IEL (green) and simultaneously acquired corresponding expression of protein (red). A through D, Bottom, Reconstruction of the confocal z-axis multiplane stack through the wall of the artery corresponding to a line drawn through the images in the upper panels at the positions indicated by arrows. Note the presence of protein staining within the holes through the IEL in both the top and bottom images. Both the Na+/K+-ATPase 2 subunit and KCa3.1 channels are highly expressed within the holes, whereas Kir2.1 and KCa2.3 channels are also highly expressed within endothelial cells and at endothelial cell borders, respectively. In these images, the Alexa Fluor 488 secondary antibody was only applied to the luminal side of the artery, and the confocal laser and PMT settings were identical for each z-stack. Bar indicates 20 µm in the x-axis in all images. Representative of at least 3 arteries. E, Quantification of protein expression within the holes through the IEL (n=3 to 5). [Holes], number of holes in the IEL/100 µm2.

	Discussion

Top Abstract Introduction Materials and Methods Results Discussion References

 
These data show that the ability of K_Ca3.1 channels to contribute to EDHF hyperpolarization depends on extracellular [Ca²⁺]_o, possibly linked to the extent of basal stimulation of the extracellular CaSRs known to colocalize with these channels in the mesenteric artery endothelium. Recruitment of K_Ca3.1 channels to EDHF hyperpolarization (and relaxation) did not appear to reflect Ca²⁺ or a Ca²⁺ release signal passing from the smooth muscle into the endothelial projections that form MEGJs. However, it may reflect a local depletion of extracellular [Ca²⁺]_o around the endothelial projections containing K_Ca3.1 as [Ca²⁺]_o enters the smooth muscle through VGCC, because recruitment was reduced in the presence of VGCC blockers to limit the ability of PE to raise muscle [Ca²⁺]_i. Finally, K_Ca3.1 channel input may be enhanced by the K⁺ ions acting on the same, or closely adjacent, cells via the Na⁺/K⁺-ATPase (and possibly K_ir channels). This suggests that K⁺ efflux through K_Ca channels discretely localized in endothelial projections may underlie its action as a "diffusible" EDHF, whereas hyperpolarization attributable to K_Ca channels expressed near interendothelial cell borders (K_Ca2.3) relies primarily on extant MEGJs for effective spread into the media.

In the rat mesenteric artery, we have recently shown that K_Ca3.1 channels are concentrated in the head region of endothelial cell projections protruding through the IEL to form MEGJs.⁵ In the endothelial cells, strong punctate signal for K_Ca3.1 channels colocalized with Cx37 and Cx40 at the interface with the smooth muscle. Furthermore, at an ultrastructural level K_Ca3.1 channels and both Cx37 and Cx40 conjugated gold label was associated with endothelial cell projections forming MEGJs. In contrast, although K_Ca2.3 channels were localized in close proximity to Cx37, Cx40, and Cx43, they appeared to be mainly adjacent to endothelial– endothelial cell gap junctions.^5,16 These observations correlate with electrophysiological and immunoprecipitation data. In the former, the contribution from K_Ca2.3 and K_Ca3.1 channels to ACh-mediated hyperpolarization could be separated. Endothelial K_Ca3.1 channel activity was only apparent when the arterial smooth muscle was depolarized and contracted (leading to EDHF repolarization to close to resting potential).⁴ In the latter, K_Ca2.3 and K_Ca3.1 channels were associated with caveolin-rich and -poor fractions of endothelial cell membrane, respectively.⁹ The present experiments subtly extend our morphological data and provide novel insight into the control of endothelial K_Ca3.1 channel activation and therefore their contribution to EDHF responses. Reconstruction of confocal z-stack images from the wall of mesenteric arteries, obtained in a physiological orientation (as opposed to perfusion fixation and flat mounting for microscopy),⁵ confirmed the restriction of K_Ca3.1 channels within endothelial cell projections but also revealed a colocalization of K_Ca2.3.

With regard to the mechanism responsible for recruiting the K_Ca3.1 channels within endothelial cell projections, this was shown to be sensitive to [Ca²⁺]_o around the outside of the projections. Reducing [Ca²⁺]_o recruited K_Ca3.1 channels to EDHF hyperpolarization. These observations are consistent with recent evidence in lean Zucker rats, in which both K_Ca2.3 and K_Ca3.1 channels contributed to EDHF hyperpolarization in arteries bathed in Krebs containing 1.6 mmol/L [Ca²⁺].² A reasonable explanation in both studies is that lowering [Ca²⁺]_o reduces basal stimulation of an extracellular G protein–linked CaSR, receptors known to colocalize with K_Ca3.1 channels in "noncaveolin" membrane fractions of mesenteric endothelial cells.⁹ Thus, lowering [Ca⁺]_o from 2.5 to 1 mmol/L reduced extracellular CaSR saturation and effectively increased availability of membrane K_Ca3.1 channels for activation by increases in [Ca²⁺]_i within the endothelial projections.

Limiting increases in smooth muscle [Ca²⁺]_i was also linked to the ability of endothelial K_Ca3.1 channels to provide significant input to EDHF hyperpolarization. Nifedipine or diltiazem reduced voltage-dependent Ca²⁺ entry into the smooth muscle, associated with a loss of K_Ca3.1 channel input to the EDHF response (evoked by ACh) and, as a consequence, sole reliance on the activation of apamin-sensitive K_Ca2.3 channels. One possible explanation is that during "normal" increases in smooth muscle [Ca²⁺]_i, K_Ca3.1 channel input to the EDHF response is enabled because the increase in smooth muscle [Ca²⁺]_i following depolarization indirectly facilitates Ca²⁺ signaling in the endothelial cell projections and activates the channels. Direct measurement of endothelial cell [Ca²⁺]_i levels in both resistance arteries and arterioles has shown that smooth muscle stimulation with PE leads to [Ca²⁺]_i increases in the endothelium.^6–8 In isolated mesenteric arteries from the rat, endothelial cell subpopulations displayed an increase in Ca²⁺ during muscle stimulation with PE, apparently reflecting spread of inositol-1,4,5-trisphosphate from the muscle to the endothelium.⁷ However, the additional movement of Ca²⁺ into endothelial cell projections (and throughout the cells)^8,23 could not be discounted by these experiments. However, signaling via this route does not appear to explain our data. We were unable to detect any difference in [Ca²⁺]_i increases to ACh within the endothelial cell projection (or whole cell) during simultaneous muscle stimulation with PE. The caveat here is that it remains possible the resolution and limitations of our system prevented detection of very small and localized changes within endothelial cell projections or discrete changes in [Ca²⁺]_i within the projections during changes in diameter.

Alternatively, Ca²⁺ entry into the contracting muscle itself may be sufficient normally to reduce the [Ca²⁺]_o in the restricted extracellular space round the endothelial cell projection. As such, this would reduce "basal" CaSR stimulation and facilitate linked K_Ca3.1 channel availability, enabling activation of the latter by the increased [Ca²⁺]_i in the projections evoked by ACh. In support of this scenario, during synchronous neuronal activity the opening of VGCCs is known to substantially deplete (1 mmol/L) extracellular [Ca²⁺]_o in the limited volume of fluid surrounding the cells.^24–26 Whatever the precise explanation, within endothelial cell projections K_Ca3.1 channel activity may be suppressed through the action of protein kinase A. In enteric neurons, protein kinase A appears to maintain the K_Ca3.1 currents underlying slow, postspike, after-hyperpolarization in a closed state.¹⁰ In our experiments, the ability of forskolin to inhibit EDHF hyperpolarization attributable to K_Ca3.1 channel activity suggests a similar mechanism operates in mesenteric endothelial cells.

One possible confounding influence in our experiments with VGCC blockers is the potential for nifedipine directly to block K_Ca3.1 channels. Dihydropyridines were initially shown to block the Gardos channel in erythrocytes,^27,28 and, more recently, Jiang et al²⁹ reported block of EDHF hyperpolarization in guinea pig cochlear artery, in which, in contrast to the mesenteric artery, hyperpolarization appears to depend on K_Ca3.1 channels alone. However, this did not appear to be a significant consideration in our experiments because: (1) diltiazem, which unlike the dihydropyridines does not block K_Ca3.1 channels,^27,29 had a similar effect to nifedipine; and (2) nifedipine did not alter hyperpolarization to the K_Ca3.1 channel activator 1-EBIO. The apparent inability of nifedipine to block K_Ca3.1 channels may relate to the experimental conditions. For example, block of the Gardos channel with nifedipine decreases with increasing extracellular K⁺, a situation that would be predicted in our experiments in the presence of PE,²⁷ or it may simply be that although K_Ca3.1 channel activation is reduced, the reduction is not sufficient to suppress the overall EDHF hyperpolarization in intact arteries.

Another important observation in our study was the ability of either ouabain or TRAM-34 to block EDHF responses in the presence of the gap junction uncoupler carbenoxolone. Although carbenoxolone did reduce EDHF hyperpolarization, this did not modify the associated arterial relaxation. However, once ouabain was added along with carbenoxolone, EDHF relaxation was abolished. Although this concentration of ouabain blocks smooth muscle hyperpolarization and relaxation to exogenous K⁺,¹⁷ it has only a small inhibitory effect against the overall EDHF hyperpolarization and relaxation in submaximally contracted arteries, because the EDHF response is sustained by MEGJs, as explained in the introduction.^13,16 However, once the MEGJ pathway is compromised, in this case with carbenoxolone, blocking the action of endogenous K⁺ significantly impacts on EDHF relaxation. The fact that a gap junction uncoupler (carbenoxolone) did not alter EDHF responses in submaximally contracted arteries, but abolished them in maximally contracted arteries, although not altering relaxation to levcromakalim, supports this scheme. Interestingly, with carbenoxolone present in submaximally contracted arteries, TRAM-34 (but not apamin) caused similar block to ouabain. This suggests that endogenous K⁺ originating from the K_Ca3.1 channels in close proximity to focused clusters of Na⁺/K⁺-ATPase underlies the ability of K⁺ to act as EDHF. In the absence of carbenoxolone, block of both K_Ca3.1 and K_Ca2.3 channels, with TRAM-34 and apamin together, is necessary to block EDHF effects.⁴ The concentration of carbenoxolone we used has been shown not to alter the [Ca²⁺]_i increase evoked in the endothelium with ACh,¹⁶ and it blocks the spread of calcein from the endothelium into the smooth muscle.⁸ Furthermore, we now show that carbenoxolone does not modify the resting potential in either the endothelial or smooth muscle cells nor the endothelial cell hyperpolarization evoked with ACh. However, notably, it did block hyperpolarization to levcromakalim from spreading through MEGJs to the endothelium. In this vessel, K_ATP channels are found only on the smooth muscle cells and not the endothelium.³⁰ Therefore, although it remains possible carbenoxolone has effects in addition to uncoupling gap junctions, this agent clearly and effectively blocks the spread of EDHF hyperpolarization through MEGJs and without disrupting the key events responsible for initiating an EDHF response via Ca²⁺ handling and K_Ca channel activation within the endothelium.

Finally, in rat mesenteric arteries, K_Ca2.3 channel activation has recently been suggested to be somehow linked to the release of CNP, with CNP then acting as an EDHF to hyperpolarize and relax the adjacent smooth muscle.²⁰ Furthermore, in this study, the natriuretic peptide receptor-C–selective antagonist M372049 was found to act synergistically with ouabain to block EDHF responses, leading to the suggestion that CNP acts alongside a K_Ca3.1-dependent signal, the 2 "arms" underpinning the EDHF response in mesenteric arteries. Although a link between K_Ca3.1 channels and Na⁺/K⁺-ATPase activation is consistent with our data, we were unable to provide any evidence to suggest that CNP plays a significant role in the EDHF response. Although M372049 clearly blocked arterial relaxation to exogenous CNP, it did not increase the inhibitory action of ouabain against EDHF hyperpolarization and relaxation, and it failed to inhibit the apamin-sensitive (K_Ca2.3 channel) component of EDHF hyperpolarization. The fact that exogenous CNP only evoked a modest relaxation without any hyperpolarization, and that M372049 did not modify EDHF responses to ACh, also argues strongly against a significant role for CNP in the EDHF response.

Overall, our data indicate a clear correlation between the discrete localization of K_Ca3.1 channels within the endothelial cell projections that form MEGJs and their respective activation during smooth muscle stimulation. A suggested outline mechanism is presented in Figure 6. The complex dynamics of [Ca²⁺]_o change within the very restricted intercellular space between muscle and endothelial cell projections may provide the key to explaining why K_Ca3.1 channels are able to contribute to EDHF hyperpolarization and relaxation during muscle contraction, dropping out as membrane potential and tension (reflecting smooth muscle [Ca²⁺]_i) return to resting levels, while K_Ca2.3 channels still continue to increase membrane potential to close to E_K. In addition, spatial clustering of K_Ca3.1 channels and Na⁺/K⁺-ATPase in a concentrated microdomain within the endothelial cell projections may serve to focus K⁺ efflux for optimal stimulation of the pump, thus amplifying and/or initiating EDHF hyperpolarization in the smooth muscle cells.

View larger version (34K): [in this window] [in a new window]   Figure 6. Suggested key steps underlying endothelial cell KCa channel activation and subsequent transfer of hyperpolarization to the mesenteric smooth muscle. Step 1: At rest in 2.5 mmol/L [Ca2+]o Krebs solution, the endothelial cell CaSR is maximally stimulated and KCa3.1 channels are in some way inactivated, possibly via protein kinase A phosphorylation. Step 2: Stimulation of the endothelium with ACh raises cytoplasmic [Ca2+]i, activating apamin-sensitive KCa2.1 channels causing hyperpolarization, which can spread through homocellular (endothelial–endothelial) and heterocellular (myoendothelial, MEGJs) gap junctions. KCa3.1 channels are not available for agonist-induced [Ca2+]i activation. Step 3: Activation of smooth muscle VDCC (with PE) causes a local "sink" of [Ca2+]o in the vicinity of the endothelial projections. This reduction reduces stimulation of the CaSR and phosphorylation of KCa3.1 channels in the projections. Step 4: At this point, ACh stimulation of the endothelium raises cytoplasmic [Ca2+]i, now activating "available" KCa3.1, as well as KCa2.3. As in Step 2, the resulting hyperpolarization spreads through endothelial–endothelial and MEGJs gap junctions but now reflects input from both KCa2.3 and KCa3.1. Facilitated by ongoing muscle depolarization, endothelial K+ efflux through KCa channels is sufficient to stimulate adjacent Na+/K+-ATPase–enhancing hyperpolarization. Further amplification may also occur through KIR channel activation within this microdomain. Because smooth muscle cells repolarize to resting levels, VGCC open probability decreases, removing the Ca2+ sink; local [Ca2+]o increases toward 2.5 mmol/L; and KCa3.1 channel activity is again removed from the control of intracellular [Ca2+]i. Gray indicates intercellular space; purple, gap junctions; red, KCa3.1 channels; yellow, KCa2.3 channels; blue, VGCCs; green, Na+/K+-ATPase; cyan, CaSR.

	Acknowledgments

 
We are grateful to Drs Lorraine McEvoy and Michaela Spitaler for carrying out some of the control experiments with carbenoxolone and the immunohistochemistry, respectively, and Polina Iarova for technical support.

Sources of Funding

Supported by the Wellcome Trust and British Heart Foundation.

Disclosures

None.

	Footnotes

 
Original received July 2, 2007; resubmission received January 22, 2008; revised resubmission received March 26, 2008; accepted March 27, 2008.

	References

Top Abstract Introduction Materials and Methods Results Discussion References

 
1. Busse R, Edwards G, Feletou M, Fleming I, Vanhoutte PM, Weston AH. EDHF: bringing the concepts together. Trends Pharmacol Sci. 2002; 23: 374–380.[CrossRef][Medline] [Order article via Infotrieve]

2. Burnham MP, Johnson IT, Weston AH. Impaired small-conductance Ca²⁺-activated K⁺ channel-dependent EDHF responses in Type II diabetic ZDF rats. Br J Pharmacol. 2006; 148: 434–441.[CrossRef][Medline] [Order article via Infotrieve]

3. Kohler R, Wulff H, Eichler I, Kneifel M, Neumann D, Knorr A, Grgic I, Kampfe D, Si H, Wibawa J, Real R, Borner K, Brakemeier S, Orzechowski HD, Reusch HP, Paul M, Chandy KG, Hoyer J. Blockade of the intermediate-conductance calcium-activated potassium channel as a new therapeutic strategy for restenosis. Circulation. 2003; 108: 1119–1125.[Abstract/Free Full Text]

4. Crane GJ, Gallagher NT, Dora KA, Garland CJ. Small and intermediate calcium-dependent K⁺ channels provide different facets of endothelium-dependent hyperpolarization in rat mesenteric artery. J Physiol. 2003; 553: 183–189.[Abstract/Free Full Text]

5. Sandow SL, Neylon CB, Chen MX, Garland CJ. Spatial separation of endothelial small- and intermediate-conductance calcium-activated potassium channels (K(Ca)) and connexins: possible relationship to vasodilator function? J Anat. 2006; 209: 689–698.[CrossRef][Medline] [Order article via Infotrieve]

6. Dora KA, Doyle MP, Duling BR. Elevation of intracellular calcium in smooth muscle causes endothelial cell generation of NO in arterioles. Proc Natl Acad Sci U S A. 1997; 94: 6529–6534.[Abstract/Free Full Text]

7. Lamboley M, Pittet P, Koenigsberger M, Sauser R, Beny JL, Meister JJ. Evidence for signaling via gap junctions from smooth muscle to endothelial cells in rat mesenteric arteries: possible implication of a second messenger. Cell Calcium. 2005; 37: 311–320.[CrossRef][Medline] [Order article via Infotrieve]

8. Kansui Y, Garland CJ, Dora KA. Enhanced spontaneous Ca²⁺ events in endothelial cells reflects signalling through myoendothelial gap junctions in pressurized mesenteric arteries. Cell Calcium. Available online ahead of print. DOI: 10.1016/j.ceca.2007.11.012.

9. Weston AH, Absi M, Ward DT, Ohanian J, Dodd RH, Dauban P, Petrel C, Ruat M, Edwards G. Evidence in favor of a calcium-sensing receptor in arterial endothelial cells: studies with calindol and Calhex 231. Circ Res. 2005; 97: 391–398.[Abstract/Free Full Text]

10. Vogalis F, Harvey JR, Furness JB. PKA-mediated inhibition of a novel K⁺ channel underlies the slow after-hyperpolarization in enteric AH neurons. J Physiol. 2003; 548: 801–814.[Abstract/Free Full Text]

11. Neylon CB, D’Souza T, Reinhart PH. Protein kinase A inhibits intermediate conductance Ca²⁺-activated K⁺ channels expressed in Xenopus oocytes. Pflugers Arch. 2004; 448: 613–620.[CrossRef][Medline] [Order article via Infotrieve]

12. Neylon CB, Fowler CJ, Furness JB. Regulation of the slow afterhyperpolarization in enteric neurons by protein kinase A. Auton Neurosci. 2006; 126–127:258–263.

13. Edwards G, Dora KA, Gardener MJ, Garland CJ, Weston AH. K⁺ is an endothelium-derived hyperpolarizing factor in rat arteries. Nature. 1998; 396: 269–272.[CrossRef][Medline] [Order article via Infotrieve]

14. Edwards G, Feletou M, Gardener MJ, Thollon C, Vanhoutte PM, Weston AH. Role of gap junctions in the responses to EDHF in rat and guinea-pig small arteries. Br J Pharmacol. 1999; 128: 1788–1794.[CrossRef][Medline] [Order article via Infotrieve]

15. Sandow SL, Tare M, Coleman HA, Hill CE, Parkington HC. Involvement of myoendothelial gap junctions in the actions of endothelium-derived hyperpolarizing factor. Circ Res. 2002; 90: 1108–1113.[Abstract/Free Full Text]

16. Mather S, Dora KA, Sandow SL, Winter P, Garland CJ. Rapid endothelial cell-selective loading of connexin 40 antibody blocks endothelium-derived hyperpolarizing factor dilation in rat small mesenteric arteries. Circ Res. 2005; 97: 399–407.[Abstract/Free Full Text]

17. Dora KA, Garland CJ. Properties of smooth muscle hyperpolarization and relaxation to K⁺ in the rat isolated mesenteric artery. Am J Physiol Heart Circ Physiol. 2001; 280: H2424–H2429.[Abstract/Free Full Text]

18. Richards GR, Weston AH, Burnham MP, Feletou M, Vanhoutte PM, Edwards G. Suppression of K⁺-induced hyperpolarization by phenylephrine in rat mesenteric artery: relevance to studies of endothelium-derived hyperpolarizing factor. Br J Pharmacol. 2001; 134: 1–5.[CrossRef][Medline] [Order article via Infotrieve]

19. Dora KA, Ings NT, Garland CJ. K_Ca channel blockers reveal hyperpolarization and relaxation to K⁺ in the rat isolated mesenteric artery. Am J Physiol Heart Circ Physiol. 2002; 283: H606–H614.[Abstract/Free Full Text]

20. Villar IC, Panayiotou CM, Sheraz A, Madhani M, Scotland RS, Nobles M, Kemp-Harper B, Ahluwalia A, Hobbs AJ. Definitive role for natriuretic peptide receptor-C in mediating the vasorelaxant activity of C-type natriuretic peptide and endothelium-derived hyperpolarising factor. Cardiovasc Res. 2007; 74: 515–525.[Abstract/Free Full Text]

21. Sandow SL, Hill CE. Incidence of myoendothelial gap junctions in the proximal and distal mesenteric arteries of the rat is suggestive of a role in endothelium-derived hyperpolarizing factor–mediated responses. Circ Res. 2000; 86: 341–346.[Abstract/Free Full Text]

22. Kansui Y, Fujii K, Nakamura K, Goto K, Oniki H, Abe I, Shibata Y, Iida M. Angiotensin II receptor blockade corrects altered expression of gap junctions in endothelial cells from hypertensive rats. Am J Physiol Heart Circ Physiol. 2004; 287: H216–H224.[Abstract/Free Full Text]

23. Isakson BE, Ramos SI, Duling BR. Ca²⁺ and inositol 1,4,5-trisphosphate-mediated signaling across the myoendothelial junction. Circ Res. 2007; 100: 246–254.[Abstract/Free Full Text]

24. Hofer AM, Brown EM. Extracellular calcium sensing and signalling. Nat Rev Mol Cell Biol. 2003; 4: 530–538.[CrossRef][Medline] [Order article via Infotrieve]

25. Keicher E, Bilbaut A, Maggio K, Hernandez-Nicaise ML, Nicaise G. The desheathed periphery of aplysia giant neuron. Fine structure and measurement of [Ca²⁺]_o fluctuations with calcium-selective microelectrodes. Eur J Neurosci. 1991; 3: 10–17.[Medline] [Order article via Infotrieve]

26. Rusakov DA, Fine A. Extracellular Ca²⁺ depletion contributes to fast activity-dependent modulation of synaptic transmission in the brain. Neuron. 2003; 37: 287–297.[CrossRef][Medline] [Order article via Infotrieve]

27. Kaji DM. Nifedipine inhibits calcium-activated K transport in human erythrocytes. Am J Physiol. 1990; 259: C332–C339.[Medline] [Order article via Infotrieve]

28. Ellory JC, Kirk K, Culliford SJ, Nash GB, Stuart J. Nitrendipine is a potent inhibitor of the Ca²⁺-activated K⁺ channel of human erythrocytes. FEBS Lett. 1992; 296: 219–221.[CrossRef][Medline] [Order article via Infotrieve]

29. Jiang ZG, Shi XR, Guan BC, Zhao H, Yang YQ. Dihydropyridines inhibit acetylcholine-induced hyperpolarization in cochlear artery via blockade of intermediate-conductance calcium-activated potassium channels. J Pharmacol Exp Ther. 2007; 320: 544–551.[Abstract/Free Full Text]

30. Takano H, Dora KA, Spitaler MM, Garland CJ. Spreading dilatation in rat mesenteric arteries associated with calcium-independent endothelial cell hyperpolarization. J Physiol. 2004; 556: 887–903.[Abstract/Free Full Text]

Related Article:

The EDHF Story: The Plot Thickens

Helena C. Parkington, Marianne Tare, and Harold A. Coleman
Circ. Res. 2008 102: 1148-1150. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

				S. L. Sandow and T. H. Grayson Limits of isolation and culture: intact vascular endothelium and BKCa Am J Physiol Heart Circ Physiol, July 1, 2009; 297(1): H1 - H7. [Abstract] [Full Text] [PDF]

				S. Brahler, A. Kaistha, V. J. Schmidt, S. E. Wolfle, C. Busch, B. P. Kaistha, M. Kacik, A.-L. Hasenau, I. Grgic, H. Si, et al. Genetic Deficit of SK3 and IK1 Channels Disrupts the Endothelium-Derived Hyperpolarizing Factor Vasodilator Pathway and Causes Hypertension Circulation, May 5, 2009; 119(17): 2323 - 2332. [Abstract] [Full Text] [PDF]

				M. J. Cipolla, J. Smith, M. M. Kohlmeyer, and J. A. Godfrey SKCa and IKCa Channels, Myogenic Tone, and Vasodilator Responses in Middle Cerebral Arteries and Parenchymal Arterioles: Effect of Ischemia and Reperfusion Stroke, April 1, 2009; 40(4): 1451 - 1457. [Abstract] [Full Text] [PDF]

				H. C. Hercule, W.-H. Schunck, V. Gross, J. Seringer, F. P. Leung, S. M. Weldon, A. Ch. da Costa Goncalves, Y. Huang, F. C. Luft, and M. Gollasch Interaction Between P450 Eicosanoids and Nitric Oxide in the Control of Arterial Tone in Mice Arterioscler. Thromb. Vasc. Biol., January 1, 2009; 29(1): 54 - 60. [Abstract] [Full Text] [PDF]

				S. Smajilovic and J. Tfelt-Hansen Novel Role of the Calcium-Sensing Receptor in Blood Pressure Modulation Hypertension, December 1, 2008; 52(6): 994 - 1000. [Full Text] [PDF]

				B. E. Isakson Localized expression of an Ins(1,4,5)P3 receptor at the myoendothelial junction selectively regulates heterocellular Ca2+ communication J. Cell Sci., November 1, 2008; 121(21): 3664 - 3673. [Abstract] [Full Text] [PDF]

				H. C. Parkington, M. Tare, and H. A. Coleman The EDHF Story: The Plot Thickens Circ. Res., May 23, 2008; 102(10): 1148 - 1150. [Full Text] [PDF]

This Article Abstract Full Text (PDF) Data Supplement All Versions of this Article: 102/10/1247    most recent CIRCRESAHA.108.172379v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dora, K. A. Articles by Garland, C. J. Search for Related Content PubMed PubMed Citation Articles by Dora, K. A. Articles by Garland, C. J. Related Collections Ion channels/membrane transport Endothelium/vascular type/nitric oxide Other Vascular biology Related Article